Lundbeck Rexulti 0.5 Mg 7 Tabletas
Por um escritor misterioso
Descrição
New Antipsychotic Agent Approved for MDD, Schizophrenia - MPR
Otsuka, Lundbeck Submit sNDA for Rexulti in Adolescents with Schizophrenia
REXULTI actuamed
WO2019121849A1 - Pharmaceutical tablet composition comprising brexpiprazole - Google Patents
FDA Approves New Schizophrenia Data for Rexulti - MPR
Rexulti 0.5mg caja con 7 tabletas
FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia Due to Alzheimer's Disease
Brexpiprazole - wikidoc
מחקרים על ריקסלטי כטיפול אוגמנטציה בדיכאון (MDD)
FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease - US FDA
de
por adulto (o preço varia de acordo com o tamanho do grupo)
